Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
7.16
-0.05 (-0.69%)
May 20, 2026, 1:35 PM CST

SHE:002349 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,4621,4461,3881,4961,5501,336
Other Revenue
13.8513.8513.6315.4122.5821.41
1,4761,4601,4021,5121,5731,358
Revenue Growth (YoY)
5.56%4.13%-7.25%-3.90%15.85%5.97%
Cost of Revenue
707.44713.15719.73781.18847.06739.21
Gross Profit
768.74746.8682.36730.58726618.66
Selling, General & Admin
398.23394.33366.72346.78401.01352.64
Research & Development
68.7864.9961.7964.6286.9874.76
Other Operating Expenses
20.9620.0417.4817.7722.3920.17
Operating Expenses
489.76479.82449.36431.89514.64462.16
Operating Income
278.98266.98233298.69211.36156.51
Interest Expense
-0.46-0.57-1.34-2.57-6.79-12.94
Interest & Investment Income
30.6130.348.3823.8739.7114.16
Currency Exchange Gain (Loss)
-2.55-2.552.342.356.86-1.48
Other Non Operating Income (Expenses)
-2.3-0.21-0.30.43-1.241.45
EBT Excluding Unusual Items
304.29293.96282.09322.76249.9157.7
Gain (Loss) on Sale of Investments
4.714.173.826.834.9931.44
Gain (Loss) on Sale of Assets
-0.03-0.01-0.2-0.09-0.06-0.58
Asset Writedown
-1-1.14-2.13-4.52-16.96-16.7
Other Unusual Items
6.626.629.754.7112.347.03
Pretax Income
314.59303.61293.32329.7250.21178.89
Income Tax Expense
42.5241.7745.8553.2337.9238.93
Earnings From Continuing Operations
272.07261.84247.47276.47212.29139.96
Minority Interest in Earnings
-49.13-42.55-34.81-28.77-0.0620.74
Net Income
222.94219.28212.65247.7212.23160.7
Net Income to Common
222.94219.28212.65247.7212.23160.7
Net Income Growth
9.40%3.12%-14.15%16.71%32.06%44.79%
Shares Outstanding (Basic)
819819814814814814
Shares Outstanding (Diluted)
820819814814814814
Shares Change (YoY)
0.66%0.58%-0.01%0.02%-0.00%-0.03%
EPS (Basic)
0.270.270.260.300.260.20
EPS (Diluted)
0.270.270.260.300.260.20
EPS Growth
8.68%2.53%-14.13%16.69%32.07%44.83%
Free Cash Flow
293.79320.54280.1262.93296.8225.02
Free Cash Flow Per Share
0.360.390.340.320.360.28
Dividend Per Share
0.0900.0900.0800.0920.0800.060
Dividend Growth
12.50%12.50%-13.04%15.00%33.33%46.34%
Gross Margin
52.08%51.15%48.67%48.33%46.15%45.56%
Operating Margin
18.90%18.29%16.62%19.76%13.44%11.53%
Profit Margin
15.10%15.02%15.17%16.38%13.49%11.83%
Free Cash Flow Margin
19.90%21.96%19.98%17.39%18.87%16.57%
EBITDA
359.49346.42308.14382.89319.43257.8
EBITDA Margin
24.35%23.73%21.98%25.33%20.31%18.99%
D&A For EBITDA
80.5179.4375.1484.21108.07101.29
EBIT
278.98266.98233298.69211.36156.51
EBIT Margin
18.90%18.29%16.62%19.76%13.44%11.53%
Effective Tax Rate
13.52%13.76%15.63%16.14%15.16%21.76%
Revenue as Reported
1,4761,4601,4021,5121,5731,358
Advertising Expenses
-9.3113.6913.657.2711.6
Source: S&P Global Market Intelligence. Standard template. Financial Sources.